Table 2.

Main study endpoints in the two study treatment groups

	Frovatriptan	Almotriptan	p
Pain-relief episodes at 2 h	28 (36)	32 (41)	NS
Pain-free episodes at 2 h	15 (19)	23 (29)	NS
Pain-relief episodes at 4 h	41 (53)	38 (50)	NS
Pain-free episodes at 4 h	36 (47)	42 (54)	NS
Pain-relief episodes at 24 h	48 (62)	53 (67)	NS
Pain-free episodes at 24 h	46 (60)	52 (67)	NS
Recurrent episodes at 24 h	6 (8)	16 (21)	<0.05
Recurrent episodes at 48 h	7 (9)	19 (24)	<0.05

Data are reported as absolute (n) and relative (%) frequency. p refers to the statistical significance of the difference between the two study drugs